AKL Therapeutics
Pre-clinicalRadically improving healthspan with a novel multifactorial approach to osteoarthritis
Founded
2018
Focus
Small Molecules
About
Radically improving healthspan with a novel multifactorial approach to osteoarthritis
Funding History
1Total raised: $2.8M
Seed$2.8MUndisclosedSep 15, 2021
Company Info
TypePrivate
Founded2018
LocationLondon, United Kingdom
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile